Eli Lilly, Novo Nordisk’s Historic GLP-1 Pricing Deals – What Investors Need To Know
FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes
The US Food and Drug Administration (FDA) recently approved Novo Nordisk’s oral semaglutide, marketed as Rybelsus, to reduce the risk of major adverse cardiac events in adults with type 2 diabetes who are at high risk of these conditions.
🎥 Tufts MD on GLP-1 and the protein obsession: ‘I worry we might be missing the mark’
Protein is hot. And the GLP-1 trend is only accelerating it, with firms competing to come up with ever more soluble and better absorbed options enabling brands to pack ever greater amounts into everything from protein water to drinkable yogurt. Loss of lean muscle mass is a well-publicized issue for people that rapidly lose weight […]
Trump Unveils Deals To Lower Costs Of Some weight-Loss Drugs
WASHINGTON:�US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs. Both companies “have agreed to offer their most popular GLP-1 weight-loss drug,” Trump said at the White House, “at drastic discounts.””Eli Lilly and Novo […]
Eli Lilly, Novo Nordisk’s Historic GLP-1 Pricing Deals – What Investors Need To Know
Post Content
LLY’s GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs
Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Despite being on the market for around three years, Mounjaro and Zepbound have become key top-line drivers for Lilly, with demand rising rapidly. Mounjaro and Zepbound account for more than 50% of the company’s total revenues. […]
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs
CEO Sean Duffy cofounded Omada Health in 2011. Omada Health Trump said Thursday that TrumpRx would offer discounts on GLP-1 drugs for weight loss. A few hours later, Omada Health said it will prescribe the drugs starting in 2026. The diabetes company previously stayed out of GLP-1 prescribing amid the Ozempic frenzy. A billion-dollar diabetes […]
Sam Altman says he tried semaglutide ‘before it was cool’ — and once ended up in a hospital
“Sometimes late at night, you just really want that chocolate chip cookie at 11:30,” Sam Altman said. Sebastian Gollnow/picture alliance via Getty Images OpenAI CEO Sam Altman said that he tried semaglutide “before it was cool” — and that it sent him to the hospital. Semaglutide is sold under brand names like Ozempic and Wegovy. Elon […]
This next-gen weight-loss drug offers a new hope — and a bonus Ozempic and Wegovy don’t have
The once-weekly shot may be a tempting alternative to popular GLP-1 class drugs like Ozempic and Wegovy
What you need to know about Medicare coverage for weight-loss drugs
The Trump administration’s pact with drugmakers to lower the price of GLP-1 drugs could pave the way for millions more to access the treatments.